GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Cash Flow for Dividends

Concord Biotech (BOM:543960) Cash Flow for Dividends : ₹-715 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Cash Flow for Dividends?

Concord Biotech's cash flow for dividends for the six months ended in Mar. 2024 was ₹0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-715 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Concord Biotech's quarterly payment of dividends increased from Mar. 2023 (₹0 Mil) to Sep. 2023 (₹-715 Mil) but then declined from Sep. 2023 (₹-715 Mil) to Mar. 2024 (₹0 Mil).

Concord Biotech's annual payment of dividends declined from Mar. 2022 (₹-705 Mil) to Mar. 2023 (₹-536 Mil) but then increased from Mar. 2023 (₹-536 Mil) to Mar. 2024 (₹-715 Mil).

Concord Biotech Cash Flow for Dividends Historical Data

The historical data trend for Concord Biotech's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Cash Flow for Dividends Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Cash Flow for Dividends
-805.45 -57.06 -705.21 -535.64 -714.53

Concord Biotech Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Cash Flow for Dividends Get a 7-Day Free Trial - -535.64 0.01 -714.53 -

Concord Biotech Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-715 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Biotech Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech (BOM:543960) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Cash Flow for Dividends
Comparable Companies
BOM:540701 BOM:543434 NSE:ZOTA BOM:531349 NSE:BALAXI BOM:500259 BOM:524717 BOM:532890 BOM:540679 BOM:524663 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
CONCORDBIO:India
Address
Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Website
https://www.concordbiotech.com
Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines